Mission 2024
Genekam making ready for Nasdaq IPO 2024
Slide 1

LATEST NEWS:

Press is reporting a fatal infection in human being with avian influenza virus H5N2 in Mexico. Genekam has a kit for this pathogen available.

Ready to use real time PCR: Fluhunter avian influenza virus H5N2 FR356 100 reactions Euro 619.-

Slide 1

LATEST NEWS:

Genekam Biotechnology AG is developing diagnostic tests for early detection of SARS CoV-2 vaccine and post vaccination complications.

Slide 1

LATEST NEWS:

Genekam Biotechnology AG has developed a small molecule with potential to treat SARS CoV-2 vaccine complication and is going to start in vitro studies.

Slide 1

MEDICA 2024

Visit us on Medica Duesseldorf, 11.-14. November 2024

Slide 1

EUDAMED

A number of Genekam products are registered with EUDAMED
A step towards meeting the lastest IVDR requirements

Products

SHOWCASE

Latest Products

CONTACT US

Do You Have Any
Questions?

  • Genekam Biotechnology AG
    Duissern Str. 65a
    47058 Duisburg, Germany

  • 49 203 / 555 858 -31 / -32 / -33
    Mobil (WhatsApp): 49 (0)170 / 3503779
    Skype: genekam-biotechnology

  • anfrage@genekam.de